SOPHIA FRONTUS: Open Payments
NPI 1518338821 · BROOKLYN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$16,526 in 31 payments from 5 companies in 2025. Trend: 2023 $4,004 · 2024 $1,989 · 2025 $16,526
Speaker / faculty: $13,680Travel & lodging: $1,720Food & beverage: $1,126
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 25 | $16,340 |
| AstraZeneca Pharmaceuticals LP | 3 | $82 |
| Caris MPI, Inc. | 1 | $43 |
| Merck Sharp & Dohme LLC | 1 | $31 |
| Genmab U.S., Inc. | 1 | $31 |
Products named: JEMPERLI, ZEJULA, LYNPARZA, MI CANCER SEEK, Tivdak.
Industry payments across NY — which companies pay providers there.
